MDA Space Q3 2026 Earnings Call - MDA SPACE LTD

Explicit Guidance:

• Full-Year 2026 Revenue: Raised to $1.90–1.95 billion (from $1.80–1.90 billion), implying ~18% YoY growth at the midpoint; excludes BCT and CLS acquisitions.
• Full-Year 2026 Adjusted EBITDA: Raised to $355–375 million (from $330–370 million), implying ~13% YoY growth at the midpoint; excludes BCT and CLS acquisitions.
• Full-Year 2026 Adjusted EBITDA Margin: Maintained range of 18%–20%.
• Full-Year 2026 Capital Expenditures (CapEx): Maintained range of $225–275 million.
• Full-Year 2026 Free Cash Flow: Maintained guidance of neutral to negative.
• FY 2026 Pro Forma Impact: BCT and CLS acquisitions (on a 2026 pro forma basis) would have contributed ~$700 million in additional revenue.
• Recurring Revenue Target: CLS acquisition expected to double company recurring revenue to >30% of annual revenue.

Business-Segment Outlook:

• Satellite Systems: Revenue performance in Q3 and Q4 expected to remain strong; 2027 growth driven by continued Telesat Lightspeed volume, Radarsat-3 replenishment satellite, and GlobalStar next-gen LEO constellation ramp-up (revenue will gradually phase down for GlobalStar replenishment but new programs will enter).
• Geointelligence: Anticipated significant acceleration post-MDA Chorus launch; CLS integration expected to serve as a "meaningful accelerant"; expected to deliver double-digit organic growth alongside new customer acquisition (over 1/3 of letters of intent for Chorus from new customers).
• Robotics & Space Operations: Canadarm-3 program expected to be a steady revenue contributor in 2027; collaboration with NASA/CSA to finalize scope for lunar surface robotics and LEO mission adaptations.
• Backlog: Ended Q3 2026 just under $4.0 billion; 2027 visibility secured via contracts totaling >$4 billion (including $1.4 billion Telesat backlog); $40 billion total opportunity pipeline underpins growth.
• Product Lines:
  • MDA Chorus: Three-satellite constellation (Radarsat-2 + 2 new) expected to launch soon; C-band (700km swath) and X-band (sub-meter resolution) capabilities targeting end-to-end geo-intelligence workflow.
  • MDA Aurora Black: Software-defined line extension with hardened cyber/physical protection for government/military; launching in LEO/MEO orbits.
  • MDA SkyMineCare & MDA Midnight: Early positioning in lunar robotics, in-orbit servicing, and commercial space stations.

Market and Competitive Outlook:

• European Market: Strategic entry point achieved via Iris Squared (Thales Alenia Space) contract for digital payload antennas; strong signal for Canadian tech in sovereign European constellations; potential for expanded content in Layer 2 and full satellite delivery as industrial base matures.
• Sovereignty Trends: Increasing global demand for sovereign satellite communications and Earth observation; anticipated growth in defense programs (e.g., German constellation, ESCAPE in Canada).
• US Market: Expansion via BCT acquisition to form "MDA Space USA" to bid as a prime contractor for US DoD; leveraging ITAR-free Canadian designs to offer US-assembled solutions with US components.
• Competitive Positioning: Confident in becoming a "leading space middle power"; ability to scale high-volume production in Montreal and partner globally (Canada, Europe, US).
• Drone/Aerospace: 49 North team active in RPAS (General Atomics) and RCN ISTAR; expanding role in Canadian military and international collaboration (e.g., Ukraine support).

Macro / Industry Outlook:

• Launch Cadence: Monitoring potential sunset of SpaceX Falcon 9 as a "legitimate watch point"; currently no heightened anxiety among customers regarding launch access or financing of new constellations.
• Regulatory/Closing: BCT acquisition expected to close later this year; CLS acquisition expected to close late 2026 or early Q1 2027, pending regulatory approvals.
• Economic Context: Management does not provide specific macro-economic guidance but emphasizes confidence in long-term demand cycles driven by defense modernization and commercial connectivity needs.
• FX/Capital: Strong net cash position ($1.3B) and total liquidity ($2.9B) provide buffer for acquisitions and working capital fluctuations; no specific FX guidance provided.

Strategic Initiatives:

• M&A:
  • Blue Canyon Technologies (BCT): Closing late 2026; aims to expand US defense market access and prime contractor status.
  • CLS (Europe): Closing late 2026/Q1 2027; expands global footprint (19 countries), geointelligence capabilities, and recurring revenue streams.
• Capacity & Technology:
  • Montreal Facility: High-volume production facility now operational; CapEx ramping down post-infrastructure build-out, but continued R&D spending anticipated for chip development (Aurora) and product innovation.
  • Launchpad Ventures: New program to identify/invest in next-gen Canadian space/defense startups.
  • Canadarm-3: Finalizing scope for NASA Artemis lunar base; planning activities for LEO mission adaptation included in recent CSA funding.
  • Iris Squared: Authorization to proceed for digital phased array antennas and controllers for Layer 1; viewed as entry point to European sovereign constellation.
• ESCAPE Program: Serving as prime contractor for end-to-end mission delivery (UHF/X-band) for Canadian government; expected to generate multi-phase, multi-billion dollar orders.

Risks and Headwinds to Outlook:

• Acquisition Closing: BCT and CLS revenues excluded from 2026 guidance pending regulatory approvals and closing conditions; timing risks remain (CLS potentially delayed to Q1 2027).
• Launch Dependencies: Potential future scarcity of launch capacity (e.g., SpaceX Falcon 9 sunset) could impact customer deployment schedules and MDA revenue realization, though no immediate disruption expected.
• Program Mix/Margins: Q3 margin decline (19.3% vs 20.2%) attributed to program mix changes and higher SG&A investments; future margins expected to remain within 18–20% despite increased R&D/SG&A spend required for scaling.
• Working Capital: 2026 Free Cash Flow guidance (neutral/negative) driven by working capital fluctuations on major programs (Telesat, Canadarm-3) and CapEx intensity.
• Geopolitical/Content Requirements: Sovereignty and domestic content requirements in European (Iris Squared) and US markets may limit initial contract scope, requiring careful industrial base management.

Management Tone on the Future:

• Confidence Level: High; characterized as "tremendous momentum" and a "very long runway ahead."
• Strategic Focus: Shifted from "hitting numbers" to "top space companies in the world"; management emphasizes disciplined execution, scaling, and productization (Aurora, Chorus, Robotics).
• Growth Trajectory: Expects "solid double-digit organic growth" in 2027; total 2027 growth expected to be "very, very significant" including acquisition impacts.
• Transparency: Will provide 2027 financial plan in March 2027; currently avoiding specific 2027 guidance due to the ongoing planning process and M&A timing.
• Self-Reflection: CEO noted the magnitude of growth (Q3 2026 revenue matching 2021 full-year revenue) as a validation of execution and market transformation.

Miscellaneous:

• GlobalStar Milestone: First commercial LEO communications constellation delivered as a prime contractor (8 satellites launched, 9 remaining expected later this year).
• MDA Chorus: 19 years after Radarsat-2 launch (2007); Chorus constellation anchored by Radarsat-2 plus two new satellites (C-band/X-band).
• Share Count: Diluted EPS unchanged YoY ($0.37) in Q3 due to share issuances in March and July offsetting higher net income; no specific buyback or share count guidance provided beyond current status.